356 related articles for article (PubMed ID: 25369348)
1. Haematopoietic developmental potential of human pluripotent stem cell lines.
Tesařová L; Simara P; Stejskal S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
[TBL] [Abstract][Full Text] [Related]
2. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
Abraham S; Sheridan SD; Miller B; Rao RR
Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
Hexum MK; Tian X; Kaufman DS
Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
[TBL] [Abstract][Full Text] [Related]
4. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
5. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.
Ramos-Mejia V; Melen GJ; Sanchez L; Gutierrez-Aranda I; Ligero G; Cortes JL; Real PJ; Bueno C; Menendez P
Mol Ther; 2010 Dec; 18(12):2173-81. PubMed ID: 20736931
[TBL] [Abstract][Full Text] [Related]
6. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
[TBL] [Abstract][Full Text] [Related]
7. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells.
Liu S; Xu Y; Zhou Z; Feng B; Huang H
Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303
[TBL] [Abstract][Full Text] [Related]
8. Vitronectin-activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells.
Shen J; Zhu Y; Zhang S; Lyu S; Lyu C; Feng Z; Hoyle DL; Wang ZZ; Cheng T
Cell Prolif; 2021 Apr; 54(4):e13012. PubMed ID: 33656760
[TBL] [Abstract][Full Text] [Related]
9. Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells.
Lu M; Kardel MD; O'Connor MD; Eaves CJ
Exp Hematol; 2009 Aug; 37(8):924-36. PubMed ID: 19481135
[TBL] [Abstract][Full Text] [Related]
10. Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies.
Emmert MY; Wolint P; Wickboldt N; Gemayel G; Weber B; Brokopp CE; Boni A; Falk V; Bosman A; Jaconi ME; Hoerstrup SP
Biomaterials; 2013 Sep; 34(27):6339-54. PubMed ID: 23727259
[TBL] [Abstract][Full Text] [Related]
11. Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials.
Guhr A; Kobold S; Seltmann S; Seiler Wulczyn AEM; Kurtz A; Löser P
Stem Cell Reports; 2018 Aug; 11(2):485-496. PubMed ID: 30033087
[TBL] [Abstract][Full Text] [Related]
12. Generation of human induced pluripotent stem cells using genome integrating or non-integrating methods.
Šimara P; Tesařová L; Padourová S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():85-9. PubMed ID: 25369347
[TBL] [Abstract][Full Text] [Related]
13. Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.
Chen T; Wang F; Wu M; Wang ZZ
J Cell Biochem; 2015 Jul; 116(7):1179-89. PubMed ID: 25740540
[TBL] [Abstract][Full Text] [Related]
14. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
[TBL] [Abstract][Full Text] [Related]
15. Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines.
Philonenko ES; Tan Y; Wang C; Zhang B; Shah Z; Zhang J; Ullah H; Kiselev SL; Lagarkova MA; Li D; Dai Y; Samokhvalov IM
J Cell Mol Med; 2021 Sep; 25(18):8701-8714. PubMed ID: 34342123
[TBL] [Abstract][Full Text] [Related]
16. Generation, expansion, and differentiation of cardiovascular progenitor cells from human pluripotent stem cells.
Cao N; Liang H; Yang HT
Methods Mol Biol; 2015; 1212():113-25. PubMed ID: 25208753
[TBL] [Abstract][Full Text] [Related]
17. Current applications of human pluripotent stem cells: possibilities and challenges.
Ho PJ; Yen ML; Yet SF; Yen BL
Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
[TBL] [Abstract][Full Text] [Related]
18. Genetic manipulation of human induced pluripotent stem cells.
Wang A; Liew CG
Curr Protoc Stem Cell Biol; 2012 Nov; Chapter 5():Unit 5B.2. PubMed ID: 23154936
[TBL] [Abstract][Full Text] [Related]
19. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes.
Emdad L; D'Souza SL; Kothari HP; Qadeer ZA; Germano IM
Stem Cells Dev; 2012 Feb; 21(3):404-10. PubMed ID: 21631388
[TBL] [Abstract][Full Text] [Related]
20. Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells.
Flamant S; Chomel JC; Desterke C; Féraud O; Gobbo E; Mitjavila-Garcia MT; Foudi A; Griscelli F; Turhan AG; Bennaceur-Griscelli A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
